Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Schizophrenia

Free Subscription 09.02.2026 1 Am J Med Genet B Neuropsychiatr Genet 2 Am J Psychiatry 1 Br J Psychiatry 1 J Clin Psychopharmacol 4 Mol Psychiatry 1 Neuropsychopharmacology 1 PLoS Genet 1 PLoS One 2 Psychiatry Res 1 Psychol Med 5 Schizophr Res

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Med Genet B Neuropsychiatr Genet

1. GAWLIK M, Schneider P, Pfuhlmann B, Deckert J, et al
   Schizophrenic Phenotype and Therapeutic Course Associated With Chromosome 22q11.2 Deletion in a Cohort Without Prior Diagnosis of Chromosome 22q11.2 Deletion Syndrome.
   Am J Med Genet B Neuropsychiatr Genet. 2026 Feb 6. doi: 10.1002/ajmgb.70008.
   PubMed         Abstract available
   
   

   
   Am J Psychiatry

2. KAUL I, Claxton A, Sauder C, Patel T, et al
   Long-Term Safety and Efficacy of Xanomeline and Trospium Chloride in Schizophrenia: A 52-Week Open-Label Extension Trial.
   Am J Psychiatry. 2026 Feb 4:appiajp20241186. doi: 10.1176/appi.ajp.20241186.
   PubMed         Abstract available
   
   
3. KALIN NH
   Neuroplasticity, Antipsychotic Efficacy, Schizophrenia Risk Reduction With Doxycycline Exposure, and Cannabis and Alcohol Use Interactions.
   Am J Psychiatry. 2026;183:87-89.
   PubMed        
   
   

   
   Br J Psychiatry

4. KARA VM
   Cultural heritage tourism as an adjunct in schizophrenia.
   Br J Psychiatry. 2026 Feb 5:1-2. doi: 10.1192/bjp.2025.10532.
   PubMed        
   
   

   
   J Clin Psychopharmacol

5. JOHN AP, Prajapati H, Dragovic M
   Reply to "Beyond Clozapine: Addressing Broader Metabolic Burden in Treatment-Resistant Schizophrenia".
   J Clin Psychopharmacol. 2026 Feb 4. doi: 10.1097/JCP.0000000000002134.
   PubMed        
   
   

   
   Mol Psychiatry

6. KINJO M, Tamura S, Sugiyama S, van Weert E, et al
   A systematic review and meta-analysis of the auditory steady-state response in schizophrenia, bipolar disorder, and autism spectrum disorder.
   Mol Psychiatry. 2026 Feb 3. doi: 10.1038/s41380-026-03452.
   PubMed         Abstract available
   
   
7. WATSON CJ, Zvrskovec J, Merola GP, Gilchrist L, et al
   Splitting schizophrenia: divergent cognitive and educational outcomes revealed by genomic structural equation modelling.
   Mol Psychiatry. 2026 Jan 31. doi: 10.1038/s41380-026-03444.
   PubMed         Abstract available
   
   
8. LLORCA-BOFI V, Parellada E, Moren C, Sellgren CM, et al
   Neuroinflammation: an unfortunate term to describe schizophrenia.
   Mol Psychiatry. 2026 Jan 31. doi: 10.1038/s41380-026-03450.
   PubMed         Abstract available
   
   
9. MEMETOGLU O, Goyal MS, Chouinard VA, Du F, et al
   Aerobic glycolysis in Schizophrenia: Developmental rescue or energetic breakdown?
   Mol Psychiatry. 2026 Jan 31. doi: 10.1038/s41380-026-03460.
   PubMed         Abstract available
   
   

   
   Neuropsychopharmacology

10. ONWORDI EC, Whitehurst T, Shatalina E, Mansur A, et al
    Whole brain grey matter synaptic terminal density, age and intellectual functioning in schizophrenia: an in vivo [(11)C]UCB-J positron emission tomography study.
    Neuropsychopharmacology. 2026 Feb 3. doi: 10.1038/s41386-026-02349.
    PubMed         Abstract available
    
    

    
    PLoS Genet

11. ZHANG C, Zhou G, Chen T, Zhao H, et al
    Joint modeling of effect sizes for two correlated traits: Characterizing trait properties to enhance polygenic risk prediction.
    PLoS Genet. 2026;22:e1012026.
    PubMed         Abstract available
    
    

    
    PLoS One

12. SMART SE, Fenner E, Humphreys R, Wells A, et al
    Genetics to Improve Outcomes in Schizophrenia (GENios): A within-case molecular genetic study protocol.
    PLoS One. 2026;21:e0340584.
    PubMed         Abstract available
    
    

    
    Psychiatry Res

13. VERIM B, Demirlek C, Zorlu N, Erdeniz B, et al
    Transdiagnostic investigation of white matter integrity and cortical thickness in cognitive subgroups within the schizophrenia-bipolar spectrum.
    Psychiatry Res. 2026;358:116964.
    PubMed         Abstract available
    
    
14. LEE T, Choi BS, Kim JH
    Cumulative incidence of schizophrenia-spectrum disorders in children and adolescents with neurodevelopmental disorders: A retrospective cohort study.
    Psychiatry Res. 2026;358:116981.
    PubMed         Abstract available
    
    

    
    Psychol Med

15. PUJJI SD, Colloca L, Waltz JA
    Placebo and Nocebo Phenomena in Schizophrenia Spectrum Disorders: A Narrative Review on Current Knowledge and Potential Future Directions - CORRIGENDUM.
    Psychol Med. 2026;56:e37.
    PubMed        
    
    

    
    Schizophr Res

16. ASCHENBRENNER EJ, Voluse AC
    Predicting the prognosis of primary and substance-associated psychoses using urine drug screens: A 5-year retrospective longitudinal study using medical records.
    Schizophr Res. 2026;290:57-64.
    PubMed         Abstract available
    
    
17. BAGALI K, Uppinkudru C, Pathak H, Parlikar R, et al
    Aberrant motor cortical plasticity in antipsychotic-resistant schizophrenia: A cross-sectional study using transcranial direct current and magnetic stimulation.
    Schizophr Res. 2026;290:48-56.
    PubMed         Abstract available
    
    
18. KRAKOWSKI M, Czobor P
    Disentangling violence in schizophrenia: Interactions between symptom trajectories, conduct disorder, and pharmacotherapy.
    Schizophr Res. 2026;290:42-47.
    PubMed         Abstract available
    
    
19. VARDEN GJERDE K, Bartz-Johannessen C, Loberg EM, Steen VM, et al
    Neural and vascular cellular adhesion molecules are associated with cognitive function in patients with schizophrenia-spectrum disorders: A longitudinal study.
    Schizophr Res. 2026;290:34-41.
    PubMed         Abstract available
    
    
20. BLACKMAN G, Morrin H, Carstairs C, Fanshawe JB, et al
    Psychopathology distinguishing secondary ("organic") psychoses: A systematic review and meta-analysis.
    Schizophr Res. 2026;289:106-111.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Schizophrenia is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum